TVN

0.00%

4.6¢ tivan limited

PB's remuneration, page-52

First 52 Last

Share
Profile

Follow
bobadah

10,433 Posts.

1155

10/11/15

13:35

Post #: 16361498
Share

Originally posted by Digity1 ↑

Of course there has been significant progression but how do you attribute “value”. Is it a warm and fuzzy thing inside that gives you confidence and belief?

I would argue that the only measurable for performance is a market capitalisation and share price. Roughly without looking back we’ve gone from a mark cap 12 mths ago of $70M. Market Cap 12mths of $120M. Let’s call it 100% increase yet the non-execs remuneration increases close to 900%.

I know $50k an invested around this time last year isn’t worth $450k.

I would also argue that they are putting their hand up on a future promise.

How do you know they will secure finance? How do you know they will not have to give half the resource away? How do you know that they won’t come back next year given clause 6.5(b)(iii) in the proposed constitution and give themselves twice, three times and much, four times as much? How do you know they won’t continue to issue themselves shares and options until they all are on the edge of the 5% holding for independence of directors? How do you know there won’t be more delays and they will need to issue another 100m shares to a Hong Kong institution (who are no longer on the register).

You don’t and the board don’t - so how about a remuneration package that is in line with the reality of the company.

Besides Paul, I highly doubt the current non-execs have the skill set or ability to get this into production. Do any have any experience in managing $1B in debt? I certainly wouldn’t won’t them managing $1B in finances and I’m sure if you look at any company that has gone from junior to a billion company, there were directors with very specific skills.

I think Paul deserves a significant kicker as I have already mentioned however the board are a collective and collectively they are way off from what the reality is. For you to state otherwise is irresponsible as a shareholder.

Regarding your comment regarding the board performance and our own greed, I don’t know what planet you live on but the shareholders own the company and as such, the AGM and voting on resolutions are the shareholders voice. You have a very strange concept of greed in saying that directors should see massive benefits before the owners of the company.

I would propose the board come back next year I’m sure if the share price is $1.00, shareholders will all be “less greedy” and be happy to vote for the directors “less greedy” proposal for remuneration of 1M bonus shares each. But wait that’s only a million dollars for each of them for free, not $5 million they'd receive upon conversion of options. Greed much??

Expand

"I would argue that the only measurable for performance is a market capitalisation and share price."

Your argument may often be a good one - but PB has/had no control of the Chinese sell down and so the argument fails in this instance (at least for the time being). Everything, as we all know, now depends on securing finance and if PB swings that then the rest does not matter. Just don't hang him for something out of his control which is really only a short term matter.

TNG Price at posting: 16.3¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 18 more messages in this thread...

First 52 Last

Add TVN (ASX) to my watchlist

(20min delay)
Last 4.6¢		Change 0.000(0.00%)		Mkt cap ! $81.11M

Open	High	Low	Value	Volume
4.6¢	4.6¢	4.5¢	$49.49K	1.077M

Buyers (Bids)

No.	Vol.	Price($)
12	1037242	4.5¢

Sellers (Offers)

Price($)	Vol.	No.
4.8¢	60870	2

View Market Depth

No.	Vol.	Price($)
11	1026198	0.045
1	227295	0.044
1	13000	0.043
1	1000000	0.042
2	90000	0.041

Price($)	Vol.	No.
0.048	60870	2
0.049	100000	1
0.050	6357261	5
0.053	147612	1
0.055	300000	1

Last trade - 15.44pm 04/10/2024 (20 minute delay)

TVN (ASX) Chart

PB's remuneration, page-52

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PB's remuneration, page-52

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News